NFKB1 and metabolic dysfunction-associated steatotic liver disease: In summary, we highlight that SFN prevents the occurrence of NAFLD by modulating the gut microbiota in mice and inhibiting the LPS-TLR4-NF-κB inflammatory pathway, implying that SFN is a potential natural product for the prevention and treatment of NAFLD.